Home » Business Information » Costs & Rebates » MTPConnect REDI Subsidy

A new funding partnership between APR.Intern and MedTech and Pharma Growth Centre (MTPConnect) will increase workforce capabilities and strengthen research translation within Australia’s medtech, biotech and pharmaceutical sector.

Under the agreement, MTPConnect’s REDI initiative will provide 25 businesses with a subsidy to ease the cost of engaging a PhD student intern. When combined with the Australian Government’s 90% rebate, this covers the entire net cost of a 3, 4 or 5-month PhD student placement.

Facilitated by APR.Intern, these short-term research placements enable innovative businesses to access Australia’s brightest emerging research talent and fast-track R&D. For universities, these placements support the development of an industry-ready PhD workforce.

This partnership falls under MTPConnect’s $32 million Researcher Exchange and Development within Industry (REDI) initiative made possible by the Medical Research Future Fund, providing industry experiences and skills development for early and mid-career researchers, clinicians and innovators to develop an industry ready workforce keeping pace with the demands of a rapidly changing sector. 

PROJECT COSTS

3-MONTH PROJECT COST: $20,000

INDUSTRY PARTNER UPFRONT COMMITMENT: $20,000

AUSTRALIAN GOVERNMENT REBATE: $18,000

MTPCONNECT SUBSIDY CONTRIBUTION: $2,000

NET COST TO BUSINESS: $0

Project cost includes a $3,000 monthly student scholarship, a one-off $5,500 academic mentor fee and a one-off $5,500 project management fee.

3 month project normally $20,000; $0 net cost with rebate and MTPConnect subsidy
4 month project normally $23,000; $0 net cost with rebate and MTPConnect subsidy
5 month project normally $26,000; $0 net cost with rebate and MTPConnect subsidy

INTERNSHIP BENEFITS

COST-EFFECTIVE

  • Access to PhD-level research expertise
  • Used for controlled practice growth
  • Suitable to fill short-term skills gaps
  • Eligible for R&D tax incentive

RAPID RESULTS

  • Results-driven 3-6 month projects
  • Quick turnaround on establishment
  • Responsive to changing business needs and priorities

HASSLE FREE

  • IP stays with business
  • No employment requirements
  • Pre-approved contract
  • Simple and transparent model
  • Proven and trusted model

INDUSTRY ELIGIBILITY

  • Proposal must have medtech, biotech or pharmaceutical relevance
  • One MTPConnect REDI subsidy per business
  • Project subject to MTPConnect review and approval

FOR MORE INFORMATION

Michael Valentine
Business Development Officer, APR.Intern

0411 600 063
m.valentine@aprintern.org.au